Our results identify short-term S100A8/A9 blockade as an important promoter of cardiac recovery post-MI, by counteracting the pro-apoptotic effects of the alarmin on endothelial cells and by favorably modulating the abundance of several proteins involved in neoangiogenesis. The gene discussed is IGKV1D-22; the disease is myocardial infarction.